Floatz logo

65 assets in Gastric Adenocarcinoma

Therapeutic assets addressing Gastric Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
[68ga]ga-nodaga-sna014
Gastric Adenocarcinoma
SmartNuclide BiopharmaEarly P1C (39)
Acc-1898
Gastric Adenocarcinoma
AccSalus Biosciences, Inc.P1C (39)
asp2138
Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc.P1C (39)
ava6103
Gastric Adenocarcinoma
Avacta Life Sciences LtdP1C (39)
Bl-M05D1
Gastric Adenocarcinoma
SystImmune Inc.P1C (39)
ct048 autologous
Gastric Adenocarcinoma
Peking UniversityP1C (39)
Disp-10
Gastric Adenocarcinoma
Dispatch BiotherapeuticsP1C (39)
ide892
Gastric Adenocarcinoma
IDEAYA BiosciencesP1C (39)
kk2269
Gastric Adenocarcinoma
Kyowa Kirin Co., Ltd.P1C (39)
MAT2A-IN-9
Gastric Adenocarcinoma
IDEAYA BiosciencesP1C (39)
Nrm-823
Gastric Adenocarcinoma
Normunity AccelCo, Inc.P1C (39)
Plx-61639
Gastric Adenocarcinoma
Plexium, Inc.P1C (39)
prt7732
Gastric Adenocarcinoma
Prelude TherapeuticsP1C (39)
177lu-ctr-fapi
Gastric Adenocarcinoma
Xijing HospitalN/AD (30)
Soluble Fluorescein
Gastric Adenocarcinoma
Mayo ClinicN/AD (30)
Showing 51 to 65 of 65 assets
PreviousPage 2 of 2Next